» Articles » PMID: 10854324

Nitric Oxide Upregulates Expression of DNA-PKcs to Protect Cells from DNA-damaging Anti-tumour Agents

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2000 Jun 15
PMID 10854324
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric-oxide synthase (NOS) activity has been detected in many human tumours, although its function is unclear. Here we show that exposure of cells to nitric oxide (NO) results in a 4-5-fold increase in expression of the DNA-dependent protein-kinase catalytic subunit (DNA-PKcs), one of the key enzymes involved in repairing double-stranded DNA breaks. This NO-mediated increase in enzymatically active DNA-PK not only protects cells from the toxic effects of NO, but also provides crossprotection against clinically important DNA-damaging agents, such as X-ray radiation, adriamycin, bleomycin and cisplatin. The NO-mediated increase in DNA-PKcs described here demonstrates the presence of a new and highly effective NO-mediated mechanism for DNA repair.

Citing Articles

Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.


Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.


Development and Evaluation of an Expedited System for Creation of Single Walled Carbon Nanotube Platforms.

Ramirez I, Sadak O, Sohail W, Huang X, Lu Y, Iverson N Carbon Lett (Korean Carbon Soc). 2024; 34(5):1343-1354.

PMID: 39015541 PMC: 11250639. DOI: 10.1007/s42823-024-00691-8.


Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy.

Kim M, Park S, Lee D Cancers (Basel). 2021; 13(22).

PMID: 34830916 PMC: 8616433. DOI: 10.3390/cancers13225762.


Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma.

Huang H, Li S, Tang Q, Zhu G Front Immunol. 2021; 12:680955.

PMID: 34566954 PMC: 8458828. DOI: 10.3389/fimmu.2021.680955.